We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 05. 11. | After market close (AMC) | $-0.28 | — | — | $0 | — | Scheduled |
| FY2023 Q3 | 2022. 09. 30. | Time TBD | — | $-27.5 | — | — | $654K | Reported |
Consensus PT $20.6 · 10 analysts
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 12. | Chardan Capital | — | Maintain | Buy → Buy | — | Chardan Capital: Buy |
| 2026. 01. 13. | Chardan Capital | — | Maintain | Buy → Buy | — | Chardan Capital: Buy |
| 2026. 01. 13. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 12. 18. | Raymond James | — | Initiate coverage | — → Strong Buy | — | Raymond James: Strong Buy |
| 2025. 12. 11. | Chardan Capital | — | Maintain | Buy → Buy | — | Chardan Capital: Buy |
| 2025. 12. 01. | Cantor Fitzgerald | — | Initiate coverage | — → Overweight | — | Cantor Fitzgerald: Overweight |